Extend your brand profile by curating daily news.

SS Innovations Promotes Vishwa Srivastava to President, Appoints Gary Lo as CFO to Drive Global Expansion

By Advos•
SS Innovations International (NASDAQ: SSII) has promoted Dr. Vishwa Srivastava to president and named Gary Lo chief financial officer, filling key leadership roles as the surgical robotics company pushes U.S. and global expansion of its SSi Mantra system.
SS Innovations Promotes Vishwa Srivastava to President, Appoints Gary Lo as CFO to Drive Global Expansion

SS Innovations International (NASDAQ: SSII), a developer of surgical robotic technologies, announced the promotion of Dr. Vishwa Srivastava to president and the appointment of Gary Lo as chief financial officer. The leadership changes come as the company advances international expansion plans for its SSi Mantra surgical robotic system and works to build its U.S. business.

Srivastava, who previously served as CEO of the company’s Asia Pacific operations, will focus on building the U.S. business and leading global operations. Both executives are based in the United States. Lo brings more than three decades of financial leadership experience across technology companies, including the medical technology sector, with expertise in capital markets, financial planning and strategic growth.

The appointments matter because SS Innovations is at a critical regulatory and commercial juncture. The company is responding to questions from the U.S. Food and Drug Administration regarding its 510(k) premarket notification while pursuing CE marking certification in the European Union. Securing FDA clearance and CE marking would open two of the world’s largest medical device markets for the SSi Mantra, a modular, multi-arm system that has been clinically validated in India in more than 190 different types of surgical procedures.

SS Innovations is also finalizing a pipeline of additional health care technologies at its research and development facility in India, with plans to introduce them in the coming months. The company’s product range includes the proprietary SSi Mantra surgical robotic system and its comprehensive suite of SSi Mudra surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. The system features 3 to 5 modular robotic arms, an open-faced ergonomic surgeon command center, a large 3D 4K monitor, and the optional SSi MantrAsana tele-surgeon console for telesurgery capability.

The company, headquartered in India but structured as a U.S. company, aims to make robotic surgery affordable and accessible to a larger segment of the global population. Its leadership appointments signal a push to strengthen U.S. operations and financial management as it navigates regulatory reviews and prepares to commercialize new technologies. Investors and industry observers can follow the latest news and updates relating to SSII in the company’s newsroom at https://nnw.fm/SSII or view the full press release at https://nnw.fm/dX3qc. For more information, visit the company’s website at ssinnovations.com or its LinkedIn page. The announcement was distributed via NetworkNewsWire, a specialized communications platform that is part of the Dynamic Brand Portfolio at IBN.

Advos

Advos

@advos